Skip to main content
Download PDF

Correction: Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial

BMC Cancer volume 22, Article number: 1348 (2022) Cite this article

The Original Article was published on 07 September 2022

Correction: BMC Cancer 22, 960 (2022)

https://doi.org/10.1186/s12885-022-09895-5

Following publication of the original article [1], the authors identified that Behrouz Najafi was omitted as the third author in the author group. The author group in this correction article has been updated and the original article [1] has been corrected.

Reference

  1. Allahyari A, Ehsanpour A, Najafi B, et al. Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial. BMC Cancer. 2022;22:960. https://doi.org/10.1186/s12885-022-09895-5.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hematology Oncology Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

    Abolghasem Allahyari

  2. Thalassemia and Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

    Ali Ehsanpour

  3. Hematology and Oncology Research Center, Razi Hospital, School of Medicine, Guilan University of Medical Science, Razi Hospital, Rasht, Iran

    Behrouz Najafi

  4. Department of Hematology & Oncology, Iran University of Medical Sciences, Tehran, Iran

    Nafseh Ansarinejad

  5. Hematology and Oncology Department, Isfahan Medical School, Isfahan, Iran

    Valiollah Mehrzad

  6. Hematology & Oncology, Department of Internal Medicine, School of Medicine, Shahid Bahonar Hospital, Kerman University of Medical Sciences, Kerman, Iran

    Behjat Kalantari

  7. Mehrad Hospital, Tehran, Iran

    Jahangir Raafat

  8. Department of Hematology and Medical Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Mojtaba Ghadiany

  9. Department of Hematology and Medical Oncology, Breast Disease Research Center, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, TUMS, Tehran, Iran

    Farhad Shahi

  10. Department of Medical Oncology & Hematology, Naft Hospital, Tehran, Iran

    Behrooz Gharib

  11. Hematology & Oncology Kerman University of Medical Sciences, Kerman, Iran

    Vahid Moazed

  12. Hematology & Oncology, Department of Adult Hematology & Oncology, School of Medicine, Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Dr. Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Adnan Khosravi

  13. Medical Oncology Guilan University of Medical Sciences, Razi Hospital, Fuman, Iran

    Mir Hossein Mirpour

  14. Medical Oncology, Hematology Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Sina Salari

  15. Hematology/Oncology Yazd Azad University, Yazd, Iran

    Seyedmohammadreza Mortazavizadeh

  16. Department of Hematology and Medical Oncology, Seyyed-al-shohada Hospital, Esfahan University of Medical Sciences, Tehran, Iran

    Amirabbas Nekoyi

  17. Medicine Saba Oncology Clinic, Isfahan, Iran

    Mohsen Khani

  18. Department of Hematology-Oncology, Isfahan University of Medical Sciences, Isfahan, Iran

    Alireza Sadeghi

  19. Hematology, Oncology Department of Internal Medicine, Guilan University of Medical Sciences, Guilan, Iran

    Sirus Gharib

  20. Department of Hematology & Oncology, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

    Alireza Bary

  21. Department of Hematology and Medical Oncology, Cancer Research Center, Cancer Institute of Iran, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

    Mehrzad Mirzania

  22. Hematology Research Center, Hematology and Medical Oncology Department, Shiraz University of Medical Sciences, Shiraz, Iran

    Shirin Haghighat

  23. Iran Medical Science University, Tehran, Iran

    Seyed Mohsen Razavi

  24. Medical Oncology, Cancer Institute, Imam Khomeini Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

    Seyed Amir Hossein Emami

  25. Hematology, Oncology Department of Internal Medicine, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

    Mehran Hosseinzadeh

  26. Hazrat Rasol Hospital Rasht, Gilan, Iran

    Mahdi Mirbolouk

  27. Internal Medicine Group TUMS Faculty of Cancer Institute of Iran, Tehran, Iran

    Sanambar Sadighi

  28. Bouali Hospital, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

    Abdolali Shahrasbi

  29. Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

    Ali Esfahani

  30. Advanced Diagnostic and Interventional Radiology Research Center, Breast Disease Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

    Masoumeh Gity

  31. Medical Department, Orchid Pharmed Company, Tehran, Iran

    Nassim Anjidani & Hamidreza Kaf

  32. Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran

    Safa Najaf

Authors
  1. Abolghasem Allahyari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ali Ehsanpour
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Behrouz Najafi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nafseh Ansarinejad
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Valiollah Mehrzad
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Behjat Kalantari
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jahangir Raafat
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mojtaba Ghadiany
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Farhad Shahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Behrooz Gharib
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Vahid Moazed
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Adnan Khosravi
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Mir Hossein Mirpour
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Sina Salari
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Seyedmohammadreza Mortazavizadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Amirabbas Nekoyi
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Mohsen Khani
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Alireza Sadeghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Sirus Gharib
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Alireza Bary
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. Mehrzad Mirzania
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. Shirin Haghighat
    View author publications

    You can also search for this author in PubMed Google Scholar

  23. Seyed Mohsen Razavi
    View author publications

    You can also search for this author in PubMed Google Scholar

  24. Seyed Amir Hossein Emami
    View author publications

    You can also search for this author in PubMed Google Scholar

  25. Mehran Hosseinzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  26. Mahdi Mirbolouk
    View author publications

    You can also search for this author in PubMed Google Scholar

  27. Sanambar Sadighi
    View author publications

    You can also search for this author in PubMed Google Scholar

  28. Abdolali Shahrasbi
    View author publications

    You can also search for this author in PubMed Google Scholar

  29. Ali Esfahani
    View author publications

    You can also search for this author in PubMed Google Scholar

  30. Masoumeh Gity
    View author publications

    You can also search for this author in PubMed Google Scholar

  31. Nassim Anjidani
    View author publications

    You can also search for this author in PubMed Google Scholar

  32. Hamidreza Kaf
    View author publications

    You can also search for this author in PubMed Google Scholar

  33. Safa Najaf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Safa Najaf.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Allahyari, A., Ehsanpour, A., Najafi, B. et al. Correction: Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial. BMC Cancer 22, 1348 (2022). https://doi.org/10.1186/s12885-022-10455-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12885-022-10455-0

BMC Cancer

ISSN: 1471-2407

Contact us